Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-15-052913
Filing Date
2015-08-31
Accepted
2015-08-31 13:53:54
Documents
5
Effectiveness Date
2015-08-31

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A v419492_defa14a.htm DEFA14A 30118
2 GRAPHIC tproxy_001.jpg GRAPHIC 720
3 GRAPHIC tproxy_002.jpg GRAPHIC 995
4 GRAPHIC tproxy_003.jpg GRAPHIC 861
5 GRAPHIC tproxy_004.jpg GRAPHIC 799
  Complete submission text file 0001144204-15-052913.txt   36678
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEFA14A | Act: 34 | File No.: 001-11504 | Film No.: 151084394
SIC: 2836 Biological Products, (No Diagnostic Substances)